Informing β-cell regeneration strategies using studies of

Current therapeutic strategies for type 1 (T1DM) and type 2 diabetes mellitus (T2DM) rely on increasing or substituting endogenous insulin secretion i…

Introducing the Lab of the Future

Deficiency of transcription factor Nkx6.1 does not prevent insulin secretion in INS-1E cells

Daniela NASTESKA, MD PhD, University of Oxford, Oxford, OX, Radcliffe Department of Medicine (RDM)

Mesenchymal Stem Cells in Cancer Therapy - PromoCell

Glucose-dependent blood flow dynamics in murine pancreatic islets in vivo

Glucose-dependent blood flow dynamics in murine pancreatic islets in vivo

Disease Modeling Using Induced Pluripotent Stem Cells

The future of diabetes treatment: Is a cure possible?

Preculturing Islets with Adipose-Derived Mesenchymal Stromal Cells is an Effective Strategy for Improving Transplantation Efficiency at the Clinically Preferred Intraportal Site - Chloe L. Rackham, Paramjeet K. Dhadda, Aurélie M. Le Lay

Glucose-dependent blood flow dynamics in murine pancreatic islets in vivo

Frontiers Stem Cell-Based Clinical Trials for Diabetes Mellitus